Cam Gallagher - Jul 6, 2021 Form 4 Insider Report for Zentalis Pharmaceuticals, Inc. (ZNTL)

Role
Director
Signature
By: /s/ Melissa B. Epperly, Attorney-in-Fact for Cam S. Gallagher
Stock symbol
ZNTL
Transactions as of
Jul 6, 2021
Transactions value $
-$861,856
Form type
4
Date filed
7/8/2021, 04:55 PM
Previous filing
Jul 6, 2021
Next filing
Aug 3, 2021

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction ZNTL Common Stock Sale -$131K -2.8K -0.55% $46.78 503K Jul 6, 2021 Direct F1, F2
transaction ZNTL Common Stock Sale -$36.3K -769 -0.15% $47.17 502K Jul 6, 2021 Direct F1, F3
transaction ZNTL Common Stock Sale -$2.64K -54 -0.01% $48.83 502K Jul 6, 2021 Direct F1, F4
transaction ZNTL Common Stock Sale -$30.6K -664 -0.13% $46.08 501K Jul 7, 2021 Direct F1, F5
transaction ZNTL Common Stock Sale -$49.6K -1.05K -0.21% $47.28 500K Jul 7, 2021 Direct F1, F6
transaction ZNTL Common Stock Sale -$41K -858 -0.17% $47.76 499K Jul 7, 2021 Direct F1, F7
transaction ZNTL Common Stock Sale -$551K -11.8K -2.36% $46.85 488K Jul 6, 2021 Direct F8, F9
transaction ZNTL Common Stock Sale -$14.9K -315 -0.06% $47.28 487K Jul 6, 2021 Direct F8, F10
transaction ZNTL Common Stock Sale -$4.9K -100 -0.02% $48.96 487K Jul 6, 2021 Direct F8
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 The sale reported in the Form 4 was effected pursuant to a Rule 10b5-1 trading arrangement adopted by the Reporting Person. Shares sold to satisfy withholding tax obligations upon the vesting of restricted stock units.
F2 The price reported is a weighted average price. The shares were sold in multiple transactions at per share prices ranging from $46.08 to $47.06. The Reporting Person undertakes to provide upon request to the SEC staff, the Issuer, or any stockholder of the Issuer, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.
F3 The price reported is a weighted average price. The shares were sold in multiple transactions at per share prices ranging from $47.08 to $48.07. The Reporting Person undertakes to provide upon request to the SEC staff, the Issuer, or any stockholder of the Issuer, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.
F4 The price reported is a weighted average price. The shares were sold in multiple transactions at per share prices ranging from $48.11 to $49.01. The Reporting Person undertakes to provide upon request to the SEC staff, the Issuer, or any stockholder of the Issuer, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.
F5 The price reported is a weighted average price. The shares were sold in multiple transactions at per share prices ranging from $45.52 to $46.50. The Reporting Person undertakes to provide upon request to the SEC staff, the Issuer, or any stockholder of the Issuer, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.
F6 The price reported is a weighted average price. The shares were sold in multiple transactions at per share prices ranging from $46.55 to $47.54. The Reporting Person undertakes to provide upon request to the SEC staff, the Issuer, or any stockholder of the Issuer, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.
F7 The price reported is a weighted average price. The shares were sold in multiple transactions at per share prices ranging from $47.56 to $48.00. The Reporting Person undertakes to provide upon request to the SEC staff, the Issuer, or any stockholder of the Issuer, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.
F8 The sale reported in the Form 4 was effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person.
F9 The price reported is a weighted average price. The shares were sold in multiple transactions at per share prices ranging from $46.23 to $47.20. The Reporting Person undertakes to provide upon request to the SEC staff, the Issuer, or any stockholder of the Issuer, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.
F10 The price reported is a weighted average price. The shares were sold in multiple transactions at per share prices ranging from $47.26 to $47.49. The Reporting Person undertakes to provide upon request to the SEC staff, the Issuer, or any stockholder of the Issuer, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.